For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Imclone Systems, Inc.

USPTO Granted Patents = 22

% Expired Patents = 13.6

Trademarks = 3

Forward Citations = 530

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Neil I Goldstein (9 out of 13 patents)

Patricia Rockwell (7 out of 8 patents)

Jeffrey G Moore (5 out of 6 patents)

4. Charles T Tackney (4 out of 5 patents)

5. Maarten J Chrispeels (3 out of 5 patents)

6. Daniel J Hicklin (2 out of 3 patents)

7. M Gabriella Colucci (2 out of 2 patents)

8. Dale Lincoln Ludwig (1 out of 18 patents)

9. Jose William Saldanha (1 out of 49 patents)

10. Zhenping Zhu (1 out of 11 patents)

11. Steven Tarran Jones (1 out of 14 patents)

12. Peter Bohlen (1 out of 3 patents)

13. Dana M Fowlkes (1 out of 30 patents)

14. P Frederick Sparling (1 out of 8 patents)

15. Fang Liao (1 out of 1 patent)

22 patents: Sort by Forward Citations

1. 7498414 - Human antibodies specific to KDR and uses thereof (2009-03-03),

2. 7371574 - Antibody antagonists of VE-cadherin without adverse effects on vascular permeability (2008-05-13),

3. 7060808 - Humanized anti-EGF receptor monoclonal antibody (2006-06-13),

4. 6991794 - Progenitor cell preservation factors and methods for and products of their use (2006-01-31),

5. 6852321 - Lectin-derived progenitor cell preservation factor and methods of use (2005-02-08),

6. 6811779 - Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy (2004-11-02),

7. 6448077 - Chimeric and humanized monoclonal antibodies specific to VEGF receptors (2002-09-10),

8. 6410723 - VDUP1 promoter and methods of use thereof (2002-06-25),

9. 6365157 - Monoclonal antibodies specific to VEGF receptors and uses thereof (2002-04-02),

10. 6310195 - Nucleic acid encoding a lectin-derived progenitor cell preservation factor (2001-10-30),

11. 6280724 - Composition and method for preserving progenitor cells (2001-08-28),

12. 6086896 - Antigenic iron repressible protein from N. meningitidis related to the (2000-07-11),

13. 6084060 - Composition and method for preserving progenitor cells (2000-07-04),

14. 5955311 - Monoclonal antibodies specific to VEGF receptors and uses thereof (1999-09-21),

15. 5874542 - Single chain antibodies specific to VEGF receptors (1999-02-23),

Imclone Systems, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative cancer treatments. The company is known for its groundbreaking monoclonal antibody therapies, particularly for the treatment of colorectal and head & neck cancers. Imclone is committed to advancing the field of oncology through research and partnerships with leading healthcare institutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

22 Patents

#374 in New York, NY

#889 in New York

#15,000 in US

#28,686 in the World

New York, NY, United States of America

Imclone Systems, Inc.

Forward Citations = 530

25 inventors:

Neil I Goldstein (9 out of 13 patents)

Patricia Rockwell (7 out of 8 patents)

Jeffrey G Moore (5 out of 6 patents)

4. Charles T Tackney (4 out of 5 patents)

5. Maarten J Chrispeels (3 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…